Sublingual immunotherapy for allergic rhinitis: An update

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 19, Issue 1, 2011, Pages 43-47

  Passalacqua, Giovanni ^a   Compalati, Enrico ^a   Canonica, Giorgio W ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

allergic rhinitis; efficacy; safety; sublingual immunotherapy

Indexed keywords

GRASS POLLEN EXTRACT; PLACEBO;

ALLERGIC RHINITIS; ARTICLE; DERMATOPHAGOIDES; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOTHERAPY; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUBLINGUAL IMMUNOTHERAPY; TREATMENT INDICATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RHINITIS, ALLERGIC, PERENNIAL; TABLETS;

EID: 78751606733     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e328341d0bd     Document Type: Article

References (61)

1. Bernstein D, Wanner B, Borish L, Liss GM. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2001; 113:1129-1136.
2. Aaronson DW, Gandhi TK. Incorrect allergy injections: allergists experiences and recommendations for prevention. J Allergy Clin Immunol 2004; 113:1117-1121.
3. Scadding K, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to dust mite. Clin Allergy 1986; 16:483-491.
4. Bousquet J, Lockey R, Malling HJ. World Health Organization position paper. Allergen immunotherapy : therapeutical vaccines for allergic diseases. Allergy 1998; 53 (Suppl 44):1-33.
5. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008; 63(Suppl 86):8-160.
6. Canonica GW, Bousquet J, Casale T, et al.World Allergy Organization position paper on sublingual immunotherapy. Allergy 2009; 64(Suppl 91):1-59.
7. Nelson H, Oppenheimer J, Vatsia GA, Buchmeier A. A double-blind, placebocontrolled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993; 92:229-236.
8. Guez S, Vatrinet C, Fadel R, André C. House dust mite sublingual swallow immunotherapy in perennial rhinitis: a double-blind placebo-controlled study. Allergy 2000; 55:369-375.
9. Roder E, Berger MY, Hop WC, et al. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 2007; 119:892-898.
10. Okubo K, Gotoh M, Fujieda S, et al. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis. Allergol Int 2008; 57:265-275.
11. Wilson DR, Torres L, Durham SR. Sublingual immunotherapy for allergic rhinitis. Allergy 2005; 60:3-8.
12. Calderon M, Mösges R, Hellmich M, Demoly P. Towards evidence-based medicine in specific grass pollen immunotherapy. Allergy 2009; 65:420-434.
13. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in children. Meta analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2006; 97:141-148.
14. Compalati E, Penagos M, Tarantini F, et al. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol 2009; 102:22-28.
15. Nieto A, Mazon A, Pamies R, et al. Sublingual immunotherapy for allergic respiratory diseases: an evaluation of meta-analyses. J Allergy Clin Immunol 2009; 124:157-161.
16. Compalati E, Passalacqua G, Bonini M, Canonica GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009; 64:1570-1579.
17. Durham SR, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once-daily grass-allergen tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117:802-809.
18. Dahl R, Kapp A, Colombo G, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118:434-440.
19. Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of oncedaily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 120:1338-1345.
20. Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5 grass pollen sublingual immunotherapy in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009; 123:160-166.
21. Ott H, Sieber J, Brehler R, et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009; 64:179-186.
22. Bufe A, Eberle P, Franke-Beckmann E, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009; 123:167-173.
23. Canonica GW, Baena Cagnani C, Bousquet J, et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007; 62:317-324.
24. Marogna M, Spadolini I, Massolo A, et al. Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. Ann Allergy Asthma Immunol 2009; 102:69-75.
25. Marogna M, Colombo F, Spadolini I, et al. Randomized open comparison of montelukast and sublingual immunotherapy as add-on treatment in moderate persistent asthma due to birch pollen. J Invest Allergol Clin Immunol 2010; 20:146-152.
26. Khinchi S, Poulsen LK, Carat F, et al. Clinical efficacy of sublingual swallow and subcutaneous immunotherapy in patients with allergic rhinoconjunctivitis due to birch pollen. A double blind double dummy placebo controlled study. Allergy 2004; 59:45-53.
27. Eifan AO, Akkoc T, Yildiz A, et al. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/ rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy 2010; 40:922-932.
28. Cox LS, Linnemann DL, Nolte H, et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006; 117:1021-1035.
29. Dunsky E, Goldstein MF, Dvorin MJ, Belecanech G. Anaphylaxis due to sublingual immunotherapy. Allergy 2006; 61:1235.
30. Antico A, Pagani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy 2006; 61:1236-1237.
31. Eifan AO, Keles S, Bahceciler NN, Barlan IB. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy 2007; 62:567-568.
32. Blazowki L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy 2008; 63:374.
33. de Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009; 64:963-964.
34. Cox L. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations. Curr Allergy Asthma Rep 2007; 7:410-420.
35. Agostinis F, Tellarini L, Falagiani P, et al. Safety of SLIT in very young children. Allergy 2004; 59:675-676.
36. Fiocchi A, Pajno G, La Grutta S, et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol 2005; 95:254-258.
37. Di Rienzo V, Minelli M, Musarra A, et al. Postmarketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005; 35:560-564.
38. Kleine-Tebbe J, Ribel M, Herold DA. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial. Allergy 2006; 61:181-184.
39. Agostinis F, Foglia C, Landi M, et al. The safety of sublingual immunotherapy with one or multiple pollen allergens in children. Allergy 2008; 63:1637-1639.
40. Lombardi C, Gargioni S, Cottini M, et al. The safety of sublingual immunotherapy with one or more allergens in adults. Allergy 2008; 63:375-376.
41. Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114:851-857.
42. Marogna M, Tomassetti D, Bernasconi A, et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 2008; 101:206-211.
43. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003; 33:206-210.
44. Tahamiler R, Saritzali G, Canakcioglu S. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope 2007; 117:965-969.
45. Durham SR, Emminger W, Kapp A, et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010; 125: 131-138.
46. Passalacqua G, Canonica GW. Sublingual immunotherapy: update 2006. Curr Opin Allergy Clin Immunol 2006; 6:449-454.
47. Lombardi C, Braga M, Incorvaia C, et al. Administration regimens for sublingual immunotherapy. What do we know? Allergy 2009; 64:849-854.
48. Guerra L, Compalati E, Rogkakou A, et al. Randomized open comparison of the safety of SLIT in a no updosing and traditional updosing schedule in patients with parietaria allergy. Allergol Immunopathol 2006; 34:82-83.
49. Rodriguez F, Boquete M, Ibanez MD, et al. Once daily sublingual immunotherapy without updosing: a new treatment schedule. Int Arch Allergy Immunol 2006; 140:321-326.
50. Agostinis F, Foglia C, Bruno ME, Falagiani P. Efficacy, safety and tolerability of sublingual monomeric allergoid in tablets given without up-dosing to pediatric patients with allergic rhinitis and/or asthma due to grass pollen. Eur Ann Allergy Clin Immunol 2009; 41:177-180.
51. Sander I, Fleischer C, Meurer U, et al. Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy. Allergy 2009; 64:1486-1492.
52. Saint-Lu N, Tourdot S, Razafindratsita A, et al. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction. Allergy 2009; 64:1003-1013.
53. Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005; 116:1073-1079.
54. Fernández-Rivas M, Garrido Fernández S, Nadal JA, et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009; 64:876-883.
55. Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mitesensitized children with atopic dermatitis: a randomized, double-blind, placebo- controlled study. J Allergy Clin Immunol 2007; 120:164-170.
56. Severino M, Cortellini G, Bonadonna P, et al. Sublingual immunotherapy for large local reactions due to honeybee sting. Double blind placebo controlled trial. J Allergy Clin Immunol 2008; 122:44-48.
57. Senna G, Ridolo E, Calderon M, et al. Evidence of adherence to allergenspecific immunotherapy. Curr Opin Allergy Clin Immunol 2009; 9:544-548.
58. Moingeon P, Batard T, Fadel R, et al. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006; 61:151-165. (Pubitemid 43381824)
59. Brozek JL, Baena Cagnani C, Canonica GW, Bonini S, et al. Methodology for development of the allergic rhinitis and its impact on Asthma guideline 2008 update. Allergy 2008; 63:38-46.
60. Casale TB, Canonica GW, Bousquet J, et al. Recommendations for appropriate sublingual immunotherapy clinical trials. J Allergy Clin Immunol 2009; 124:665-670.
61. Passalacqua G, Pawankar R, Baena-Cagnani CE, Canonica GW. Sublingual immunotherapy: where do we stand? Present and future. Curr Opin Allergy Clin Immunol 2009; 9:1-3.